Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value:
$376.98M
Total Bought:
$61.26M
Total Sold:
$25.30M
Net Transaction:
+$35.96M
Notable People:
Anna Cosslett Yaeger
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Enliven Therapeutics Inc5,160,9755,160,9750$70.50M$71.43M18.95%+$929.0K
Entrada Therapeutics, Inc.(TRDA)4,408,3794,408,3790$69.65M$66.52M17.65%-$3.13M
Pharvaris N V
COM
587,600797,600+210,000$12.26M$22.37M5.93%+$10.11M
Celldex Therapeutics, Inc.(CLDX)310,270497,270+187,000$8.54M$19.72M5.23%+$11.18M
MoonLake ImmunotherapeuticsCL A(MLTX)313,210302,630-10,580$17.85M$18.28M4.85%+$422.9K
Biohaven Ltd.(BHVN)0399,972+399,972$0$17.12M4.54%+$17.12M
Disc Medicine, Inc.(IRON)438,442294,221-144,221$20.60M$16.99M4.51%-$3.60M
Dianthus Therapeutics, Inc.(DNTH)1,472,2641,472,2640$20.13M$15.31M4.06%-$4.81M
Merus N V0521,531+521,531$0$14.34M3.80%+$14.34M
Vor Biopharma Inc.(VOR)6,361,7236,361,7230$13.49M$14.31M3.80%+$827.0K
Viridian Therapeutics, Inc.(VRDN)410,000586,595+176,595$6.29M$12.78M3.39%+$6.49M
Mirati Therapeutics Inc192,500192,5000$8.39M$11.31M3.00%+$2.92M
Viking Therapeutics, Inc.(VKTX)585,000585,0000$6.48M$10.89M2.89%+$4.41M
Rallybio Corporation(RLYB)3,630,7243,630,7240$12.24M$8.68M2.30%-$3.56M
Tyra Biosciences, Inc.(TYRA)411,450554,979+143,529$5.67M$7.69M2.04%+$2.02M
Anaptysbio Inc357,733357,7330$6.42M$7.66M2.03%+$1.24M
Scpharmaceuticals Inc1,200,6471,200,6470$8.55M$7.53M2.00%-$1.02M
Zentalis Pharmaceuticals, Inc.(ZNTL)490,000490,0000$9.83M$7.42M1.97%-$2.41M
Spruce Biosciences Inc2,364,0002,364,0000$5.34M$6.93M1.84%+$1.58M
Avidity Biosciences Inc665,555665,5550$4.25M$6.02M1.60%+$1.78M
Cogent Biosciences, Inc.(COGT)790,440790,4400$7.71M$4.65M1.23%-$3.06M
Mersana Therapeutics Inc1,305,0001,305,0000$1.66M$3.03M0.80%+$1.37M
Homology Medicines Inc4,535,9194,535,9190$5.31M$2.76M0.73%-$2.55M
GH Research PLC(GHRS)404,404404,4040$4.06M$2.35M0.62%-$1.72M
Cidara Therapeutics Inc1,134,5111,134,5110$1.07M$900.8K0.24%-$168.1K
ARVINAS INCCOM(ARVN)320,0000-320,000$6.28M$0—-$6.28M
CRINETICS PHARMACEUTICALS INCOM(CRNX)462,2860-462,286$13.75M$0—-$13.75M
IMPEL PHARMACEUTICALS INCCOM2,884,7910-2,884,791$1.24M$0—-$1.24M
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q4 2023 | TickerTrail